Table 1 Baseline characteristics of the derivation and validation cohorts
Derivation Cohort | Validation Cohort | |||
|---|---|---|---|---|
n=90 | n=314 | |||
n | Value | n | Value | |
Nr. of patients (n) | 90 | 314 | ||
Male gender n (%) | 90 | 62 (69) | 314 | 203 (65) |
Age, mean (SD), years | 72 (11) | 66 (11) | ||
Cardiovascular risk factors | ||||
Hypertension, n (%) | 89 | 69 (78) | 314 | 255 (81) |
Dyslipidemia, n (%) | 89 | 31 (35) | 314 | 232 (74) |
Diabetes mellitus, n (%) | 89 | 23 (26) | 314 | 64 (20) |
Active smoker, n (%) | 89 | 17 (19) | 314 | 53 (17) |
Obesity, n (%) | 87 | 21 (24) | 291 | 82 (28) |
Family history, n (%) | 89 | 6 (7) | 314 | 95 (30) |
Laboratory parameters on admission | ||||
Troponin I, median (IQR), ng/mL | 90 | 0.95 (0.03, 2.9) | 311 | 0.01 (0.01, 0.03) |
Troponin I > 99th percentile, n (%) | 90 | 67 (74) | 311 | 74 (24) |
eGFRMDRD, mean (SD), ml/min | 86 | 73 (25) | 314 | 77 (22) |
Clinical variables | ||||
Systolic Blood Pressure, mean (SD), mmHg | 86 | 133 (31) | 310 | 144 (24) |
Heart rate, mean (SD), bpm | 89 | 84 (32) | 310 | 77 (19) |
Chest pain onset time, median (IQR), h | 8.6 (2.9 15.5) | 4.3 (2.0, 13.2) | ||
Final diagnosis AMI type 1, n (%) | 90 | 75 (83) | 314 | 63 (20) |